• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (72)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Amyotrophic Lateral Sclerosis  • Neuromuscular diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Felix Geser, MD; Nicholas J. Brandmeir, MS; Linda K. Kwong, PhD; Maria Martinez-Lage, MD; Lauren Elman, MD; Leo McCluskey, MD; Sharon X. Xie, PhD; Virginia M.-Y. Lee, PhD, MBA; John Q. Trojanowski, MD, PhD

Arch Neurol. 2008;65(5):636-641.

Background  Pathological 43-kDa transactivating responsive sequence DNA-binding protein (TDP-43) has been identified recently as the major disease protein in amyotrophic lateral sclerosis (ALS), and in frontotemporal lobar degeneration with ubiquitinated inclusions, with or without motor neuron disease, but the distribution of TDP-43 pathology in ALS may be more widespread than previously described.

Objective  To determine the extent of TDP-43 pathology in the central nervous systems of patients with clinically confirmed and autopsy confirmed diagnoses of ALS.

Design  Performance of an immunohistochemical whole–central nervous system scan for evidence of pathological TDP-43 in ALS patients.

Setting  An academic medical center.

Participants  We included 31 patients with clinically and pathologically confirmed ALS and 8 control participants.

Main Outcome Measures  Immunohistochemistry and double-labeling immunofluorescence to assess the frequency and severity of TDP-43 pathology.

Results  In addition to the stereotypical involvement of upper and lower motor neurons, neuronal and glial TDP-43 pathology was present in multiple areas of the central nervous systems of ALS patients, including in the nigro-striatal system, the neocortical and allocortical areas, and the cerebellum, but not in those of the controls.

Conclusions  These findings suggest that ALS does not selectively affect only the pyramidal motor system, but rather is a multisystem neurodegenerative TDP-43 proteinopathy.

Author Affiliations: Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Alzheimer's Disease Core Center, Institute on Aging (Drs Geser, Kwong, Martinez-Lage, Lee, and Trojanowski, and Mr Brandmeir), Department of Neurology (Drs Elman McCluskey), and Department of Biostatistics and Epidemiology (Dr Xie), University of Pennsylvania School of Medicine, Philadelphia; and the Neurosciences Institute, Albany Medical College, Albany, New York (Mr Brandmeir).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(5):572-573.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

TDP-43 Is Directed to Stress Granules by Sorbitol, a Novel Physiological Osmotic and Oxidative Stressor
Dewey et al.
Mol. Cell. Biol. 2011;31:1098-1108.
ABSTRACT | FULL TEXT  

Degeneration of the Mid-Cingulate Cortex in Amyotrophic Lateral Sclerosis Detected In Vivo with MR Spectroscopy
Sudharshan et al.
Am. J. Neuroradiol. 2011;32:403-407.
ABSTRACT | FULL TEXT  

Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases
Donaghy et al.
J. Neurol. Neurosurg. Psychiatry 2011;82:110-116.
ABSTRACT | FULL TEXT  

Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis
Meier et al.
Brain 2010;133:3444-3457.
ABSTRACT | FULL TEXT  

Pathological 43-kDa Transactivation Response DNA-Binding Protein in Older Adults With and Without Severe Mental Illness
Geser et al.
Arch Neurol 2010;67:1238-1250.
ABSTRACT | FULL TEXT  

TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Lagier-Tourenne et al.
Hum Mol Genet 2010;0:ddq137v3-ddq137.
ABSTRACT | FULL TEXT  

Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone
Custer et al.
Hum Mol Genet 2010;19:1741-1755.
ABSTRACT | FULL TEXT  

Prion-like disorders: blurring the divide between transmissibility and infectivity
Cushman et al.
J. Cell Sci. 2010;123:1191-1201.
ABSTRACT | FULL TEXT  

TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration
Wils et al.
Proc. Natl. Acad. Sci. USA 2010;107:3858-3863.
ABSTRACT | FULL TEXT  

Transactive Response DNA-Binding Protein 43 Burden in Familial Alzheimer Disease and Down Syndrome
Lippa et al.
Arch Neurol 2009;66:1483-1488.
ABSTRACT | FULL TEXT  

Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis
Pesiridis et al.
Hum Mol Genet 2009;18:R156-R162.
ABSTRACT | FULL TEXT  

Clinical and Pathological Continuum of Multisystem TDP-43 Proteinopathies
Geser et al.
Arch Neurol 2009;66:180-189.
ABSTRACT | FULL TEXT  

Amyotrophic Lateral Sclerosis-Plus Syndrome With TAR DNA-Binding Protein-43 Pathology
McCluskey et al.
Arch Neurol 2009;66:121-124.
ABSTRACT | FULL TEXT